Lina Dagnino Selected Research

Lina Dagnino Research Topics

4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
4	Retinoblastoma (Glioblastoma, Retinal) 11/2010 - 09/2002
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
3	Neoplasms (Cancer) 12/2019 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 01/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 03/2005
1	Contact Dermatitis (Eczema, Contact) 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Carcinogenesis 12/2019
1	Cicatrix (Scar) 06/2013
1	Wounds and Injuries (Trauma) 06/2013
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Skin Abnormalities 03/2005

6	Proteins (Proteins, Gene)FDA Link 06/2013 - 09/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019 - 03/2005
2	CateninsIBA 01/2021 - 03/2019
2	Protein Isoforms (Isoforms)IBA 12/2019 - 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	Phorbol EstersIBA 01/2020
1	CytokinesIBA 01/2020
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 12/2019
1	Oncogene Proteins (Oncogene Protein)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 03/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	ConnexinsIBA 01/2017
1	Connexin 43 (Connexin43)IBA 01/2017
1	Messenger RNA (mRNA)IBA 11/2010
1	Angiopoietin-2IBA 03/2005
1	AngiopoietinsIBA 03/2005
1	Angiopoietin-1IBA 03/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2005
1	CyclinsIBA 01/2005

1	Investigational Therapies (Experimental Therapy) 03/2019
1	Therapeutics 06/2013